MicroRNAs cooperatively inhibit a network of tumor suppressor genes to promote pancreatic tumor growth and progression

Gastroenterology

Volumn 146, Issue 1, 2014, Pages

  Frampton, Adam E ^a   Castellano, Leandro ^a   Colombo, Teresa ^b   Giovannetti, Elisa ^c   Krell, Jonathan ^a   Jacob, Jimmy ^a   Pellegrino, Loredana ^a   Roca Alonso, Laura ^a   Funel, Niccola ^d   Gall, Tamara M H ^a   De Giorgio, Alexander ^a   Pinho, Filipa G ^a   Fulci, Valerio ^b   Britton, David J ^e   Ahmad, Raida ^a   Habib, Nagy A ^a   Coombes, R Charles ^a   Harding, Victoria ^a   Knösel, Thomas ^f   Stebbing, Justin ^a   Jiao, Long R ^a   more..

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF PISA   (Italy)

^e KING'S COLLEGE LONDON   (United Kingdom)

^f UNIVERSITY OF MUNICH   (Germany)

Author keywords

miRNA mRNA Interaction; Oncogene; Pancreatic Cancer; Tumorigenesis

Indexed keywords

ANTINEOPLASTIC AGENT; ATELOCOLLAGEN; MICRORNA; MICRORNA 21; MICRORNA 21 INHIBITOR; MICRORNA 23A; MICRORNA 23A INHIBITOR; MICRORNA 27A; MICRORNA 27A INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER SURGERY; CARCINOGENESIS; CARCINOMA CELL; CONTROLLED STUDY; DOWN REGULATION; DRUG INHIBITION; DRUG POTENCY; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE REGULATORY NETWORK; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; SURVIVAL TIME; TUMOR SUPPRESSOR GENE; TUMOR XENOGRAFT; UPREGULATION;

EID: 84890708492     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2013.10.010     Document Type: Article

References (79)

1. R. Siegel, E. Ward, and O. Brawley Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths CA Cancer J Clin 61 2011 212 236
2. A. Vincent, J. Herman, and R. Schulick Pancreatic cancer Lancet 378 2011 607 620
3. C.R. Ferrone, R. Pieretti-Vanmarcke, and J.P. Bloom Pancreatic ductal adenocarcinoma: long-term survival does not equal cure Surgery 152 Suppl 1 2012 S43 S49
4. S.M. Hong, J.Y. Park, and R.H. Hruban Molecular signatures of pancreatic cancer Arch Pathol Lab Med 135 2011 716 727
5. H. Siomi, and M.C. Siomi Posttranscriptional regulation of microRNA biogenesis in animals Mol Cell 38 2010 323 332
6. A. Esquela-Kerscher, and F.J. Slack Oncomirs - microRNAs with a role in cancer Nat Rev Cancer 6 2006 259 269
7. H. Xia, and K.M. Hui MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics Cancer Gene Ther 19 2012 723 730
8. B. Zhang, X. Pan, and G.P. Cobb microRNAs as oncogenes and tumor suppressors Dev Biol 302 2007 1 12
9. G.A. Calin, and C.M. Croce MicroRNA signatures in human cancers Nat Rev Cancer 6 2006 857 866
10. M. Osaki, F. Takeshita, and T. Ochiya MicroRNAs as biomarkers and therapeutic drugs in human cancer Biomarkers 13 2008 658 670
11. M. Bloomston, W.L. Frankel, and F. Petrocca MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis JAMA 297 2007 1901 1908
12. T. Greither, L. Grochola, and A. Udelnow Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumours associates with poorer survival Int J Cancer 126 2010 73 80
13. N.B. Jamieson, D.C. Morran, and J.P. Morton MicroRNA molecular profiles associated with diagnosis, clinicopathologic criteria, and overall survival in patients with resectable pancreatic ductal adenocarcinoma Clin Cancer Res 18 2012 534 545
14. T.R. Donahue, L.M. Tran, and R. Hill Integrative survival-based molecular profiling of human pancreatic cancer Clin Cancer Res 18 2012 1352 1363
15. E. Giovannetti, N. Funel, and G.J. Peters MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity Cancer Res 70 2010 4528 4538
16. X. Fu, Y. Han, and Y. Wu Prognostic role of microRNA-21 in various carcinomas: a systematic review and meta-analysis Eur J Clin Invest 41 2011 1245 1253
17. L.R. Jiao, A.E. Frampton, and J. Jacob MicroRNAs targeting oncogenes are down-regulated in pancreatic malignant transformation from benign tumors PLoS One 7 2012 e32068
18. M. Yihui, Y. Shuangni, and Z. Wugan miR-27a regulates the growth, colony formation and migration of pancreatic cancer cells by targeting Sprouty2 Cancer Lett 298 2010 150 158
19. M. Preis, T.B. Gardner, and S.R. Gordon MicroRNA-10b expression correlates with response to neoadjuvant therapy and survival in pancreatic ductal adenocarcinoma Clin Cancer Res 17 2011 5812 5821
20. E.C. Lai Micro RNAs are complementary to 3[prime] UTR sequence motifs that mediate negative post-transcriptional regulation Nat Genet 30 2002 363 364
21. D. Betel, A. Koppal, and P. Agius Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites Genome Biol 11 2010 R90
22. X. Ma, M. Kumar, and S.N. Choudhury Loss of the miR-21 allele elevates the expression of its target genes and reduces tumorigenesis Proc Natl Acad Sci U S A 108 2011 10144 10149
23. A.L. Kasinski, and F.J. Slack Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy Nat Rev Cancer 11 2011 849 864
24. Y. Zhang, A.E. Frampton, and P. Cohen Tumor infiltration in the medial resection margin predicts survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma J Gastrointest Surg 16 2012 1875 1882
25. G. Zhang, A. Schetter, and P. He DPEP1 inhibits tumor cell invasiveness, enhances chemosensitivity and predicts clinical outcome in pancreatic ductal adenocarcinoma PLoS One 7 2012 e31507
26. A.M. Qazi, O. Gruzdyn, and A. Semaan Restoration of E-cadherin expression in pancreatic ductal adenocarcinoma treated with microRNA-101 Surgery 152 2012 704 713
27. N. Funel, E. Giovannetti, and M. Del Chiaro Laser microdissection and primary cell cultures improve pharmacogenetic analysis in pancreatic adenocarcinoma Lab Invest 88 2008 773 784
28. H. Guo, N.T. Ingolia, and J.S. Weissman Mammalian microRNAs predominantly act to decrease target mRNA levels Nature 466 2010 835 840
29. D. Baek, J. Villen, and C. Shin The impact of microRNAs on protein output Nature 455 2008 64 71
30. Y. Nagao, M. Hisaoka, and A. Matsuyama Association of microRNA-21 expression with its targets, PDCD4 and TIMP3, in pancreatic ductal adenocarcinoma Mod Pathol 25 2012 112 121
31. S. Ali, K. Almhanna, and W. Chen Differentially expressed miRNAs in the plasma may provide a molecular signature for aggressive pancreatic cancer Am J Transl Res 3 2011 28 47
32. I. Jutooru, G. Chadalapaka, and M. Abdelrahim Methyl 2-cyano-3,12- dioxooleana-1,9-dien-28-oate decreases specificity protein transcription factors and inhibits pancreatic tumor growth: role of microRNA-27a Mol Pharmacol 78 2010 226 236
33. Y. Ma, S. Yu, and W. Zhao miR-27a regulates the growth, colony formation and migration of pancreatic cancer cells by targeting Sprouty2 Cancer Lett 298 2010 150 158
34. D. Sayed, S. Rane, and J. Lypowy MicroRNA-21 targets Sprouty2 and promotes cellular outgrowths Mol Biol Cell 19 2008 3272 3282
35. D. Chen, Y. Sun, and Y. Wei LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker Nat Med 18 2012 1511 1517
36. S. Ali, H. Saleh, and S. Sethi MicroRNA profiling of diagnostic needle aspirates from patients with pancreatic cancer Br J Cancer 107 2012 1354 1360
37. N. Funel, E. Giovannetti, and L.E. Pollina Critical role of laser microdissection for genetic, epigenetic and proteomic analyses in pancreatic cancer Expert Rev Mol Diagn 11 2011 695 701
38. U. Rudloff, U. Bhanot, and W. Gerald Biobanking of human pancreas cancer tissue: impact of ex-vivo procurement times on RNA quality Ann Surg Oncol 17 2010 2229 2236
39. S. Pradervand, A. Paillusson, and J. Thomas Affymetrix Whole-Transcript Human Gene 1.0 ST array is highly concordant with standard 3′ expression arrays Biotechniques 44 2008 759 762
40. G.K. Geiss, R.E. Bumgarner, and B. Birditt Direct multiplexed measurement of gene expression with color-coded probe pairs Nat Biotechnol 26 2008 317 325
41. Y. Benjamini, and Y. Hochberg Controlling the false discovery rate: a practical and powerful approach to multiple testing J R Stat Soc 57 1995 289 300
42. S. Ma, and J. Huang Regularized gene selection in cancer microarray meta-analysis BMC Bioinform 10 2009 1
43. H.C. Harsha, K. Kandasamy, and P. Ranganathan A compendium of potential biomarkers of pancreatic cancer PLoS Med 6 2009 e1000046
44. R. Grutzmann, H. Boriss, and O. Ammerpohl Meta-analysis of microarray data on pancreatic cancer defines a set of commonly dysregulated genes Oncogene 24 2005 5079 5088
45. G. Feng, P. Shaw, and S.T. Rosen Using the bioconductor gene answers package to interpret gene lists J. Wang, A.C. Tan, T. Tian, Next Generation Microarray Bioinformatics Vol 802 2012 Humana Press New York 101 112
46. M. Kanehisa, S. Goto, and M. Furumichi KEGG for representation and analysis of molecular networks involving diseases and drugs Nucleic Acids Res 38 2010 D355 D360
47. M. Ashburner, C.A. Ball, and J.A. Blake Gene ontology: tool for the unification of biology. The Gene Ontology Consortium Nat Genet 25 2000 25 29
48. B.P. Lewis, C.B. Burge, and D.P. Bartel Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets Cell 120 2005 15 20
49. S. Durinck, P.T. Spellman, and E. Birney Mapping identifiers for the integration of genomic datasets with the R/Bioconductor package biomaRt Nat Protocols 4 2009 1184 1191
50. D. Betel, A. Koppal, and P. Agius Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites Genome Biol 11 2010 R90
51. Y. Ma, S. Yu, and W. Zhao miR-27a regulates the growth, colony formation and migration of pancreatic cancer cells by targeting Sprouty2 Cancer Lett 298 2010 150 158
52. B. Sipos, S. Moser, and H. Kalthoff A comprehensive characterization of pancreatic ductal carcinoma cell lines: towards the establishment of an in vitro research platform Virchows Arch 442 2003 444 452
53. N. Funel, E. Giovannetti, and M. Del Chiaro Laser microdissection and primary cell cultures improve pharmacogenetic analysis in pancreatic adenocarcinoma Lab Invest 88 2008 773 784
54. Z. Hamidov, A. Altendorf-Hofmann, and Y. Chen Reduced expression of desmocollin 2 is an independent prognostic biomarker for shorter patients survival in pancreatic ductal adenocarcinoma J Clin Pathol 64 2011 990 994
55. R. Pirker, J.R. Pereira, and J. von Pawel EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX study Lancet Oncol 13 2012 33 42
56. J.J.M. Eekels, A.O. Pasternak, and A.M. Schut A competitive cell growth assay for the detection of subtle effects of gene transduction on cell proliferation Gene Ther 19 2012 1058 1064
57. I. Takigami, T. Ohno, and Y. Kitade Synthetic siRNA targeting the breakpoint of EWS/Fli-1 inhibits growth of Ewing sarcoma xenografts in a mouse model Int J Cancer 128 2011 216 226
58. Y. Minakuchi, F. Takeshita, and N. Kosaka Atelocollagen-mediated synthetic small interfering RNA delivery for effective gene silencing in vitro and in vivo Nucleic Acids Res 32 2004 e109
59. H. Tazawa, N. Tsuchiya, and M. Izumiya Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells Proc Natl Acad Sci 104 2007 15472 15477
60. D.R. Rhodes, J. Yu, and K. Shanker ONCOMINE: a cancer microarray database and integrated data-mining platform Neoplasia 6 2004 1 6
61. T. Barrett, D.B. Troup, and S.E. Wilhite NCBI GEO: archive for functional genomics data sets - 10 years on Nucleic Acids Res 39 2011 D1005 D1010
62. G. Zhang, A. Schetter, and P. He DPEP1 inhibits tumor cell invasiveness, enhances chemosensitivity and predicts clinical outcome in pancreatic ductal adenocarcinoma PLoS One 7 2012 e31507
63. J.L. Cmarik, H. Min, and G. Hegamyer Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformation Proc Natl Acad Sci U S A 96 1999 14037 14042
64. Y. Nagao, M. Hisaoka, and A. Matsuyama Association of microRNA-21 expression with its targets, PDCD4 and TIMP3, in pancreatic ductal adenocarcinoma Mod Pathol 25 2012 112 121
65. I. Bhatti, A. Lee, and V. James Knockdown of microRNA-21 inhibits proliferation and increases cell death by targeting programmed cell death 4 (PDCD4) in pancreatic ductal adenocarcinoma J Gastrointest Surg 15 2011 199 208
66. Z. Lu, M. Liu, and V. Stribinskis MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene Oncogene 27 2008 4373 4379
67. D. Guardavaccaro, G. Corrente, and F. Covone Arrest of G1-S progression by the p53-inducible gene PC3 is Rb dependent and relies on the inhibition of cyclin D1 transcription Mol Cell Biol 20 2000 1797 1815
68. A.D. Boiko, S. Porteous, and O.V. Razorenova A systematic search for downstream mediators of tumor suppressor function of p53 reveals a major role of BTG2 in suppression of Ras-induced transformation Genes Dev 20 2006 236 252
69. S. Seton-Rogers Tumorigenesis: pushing pancreatic cancer to take off Nat Rev Cancer 12 2012 739
70. O. Balaga, Y. Friedman, and M. Linial Toward a combinatorial nature of microRNA regulation in human cells Nucleic Acids Res 40 2012 9404 9416
71. S. Gao, C. Alarcon, and G. Sapkota Ubiquitin ligase Nedd4L targets activated Smad2/3 to limit TGF-beta signaling Mol Cell 36 2009 457 468
72. V. Ellenrieder, S.F. Hendler, and W. Boeck Transforming growth factor beta1 treatment leads to an epithelial-mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activation Cancer Res 61 2001 4222 4228
73. C. Chen, and L. Matesic The Nedd4-like family of E3 ubiquitin ligases and cancer Cancer Metast Rev 26 2007 587 604
74. C. Gao, L. Pang, and C. Ren Decreased expression of Nedd4L correlates with poor prognosis in gastric cancer patient Med Oncol 29 2012 1733 1738
75. T. Takeuchi, Y. Adachi, and T. Nagayama Nedd4L modulates the transcription of metalloproteinase-1 and -13 genes to increase the invasive activity of gallbladder cancer Int J Exp Pathol 92 2011 79 86
76. X.Y. Hu, Y.M. Xu, and Q. Fu Nedd4L expression is downregulated in prostate cancer compared to benign prostatic hyperplasia Eur J Surg Oncol 35 2009 527 531
77. S. He, J. Deng, and G. Li Down-regulation of Nedd4L is associated with the aggressive progression and worse prognosis of malignant glioma Jpn J Clin Oncol 42 2012 196 201
78. A. Siepel, G. Bejerano, and J.S. Pedersen Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes Genome Res 15 2005 1034 1050
79. M.E. Smoot, K. Ono, and J. Ruscheinski Cytoscape 2.8: new features for data integration and network visualization Bioinformatics 27 2011 431 432